Clinical trial

Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

Recruiting now · Not applicable · 1 countries · Registry ID NCT07043166

Recruiting nowNot applicableObservational

What this study is about

The main purpose of this study is to conduct follow-up assessments and update the cardiorenal outcomes among the STONE cohort that was established during 2016-2017. The secondary aim is to compare metabolic risk factors, metabolic disturbances, and clinically relevant metabolic outcomes between the follow-up period and the baseline assessment. The exploratory goal is to examine the relationships between changes in risk factors and clinical outcomes in the participants. The study is planned to begin in May 2025 and will finalize the data collection for the entire population by June 2026. During this time, participants will be categorized based on CKM staging. The follow-up phase will continue until 2035.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to Not listed

SexAll

Healthy volunteersAccepted

ConditionMetabolic Syndrome, Diabetes, Obesity and Overweight, Hypertension, Dyslipidemia, Thyroid Diseases, Bone Metabolism Disorder, Chronic Kidney Disease(CKD), Cardiovascular Diseases (CVD), Cardiovascular-kidney-metabolic Syndrome

Full registry criteria

Inclusion Criteria: 1. The 4,094 residents of Shanghai communities who have been enrolled in the STONE cohort. 2. Individuals who completed the baseline questionnaire survey, physical examination, and related clinical tests between 2016 and 2017, with complete data records. 3. Willingness to participate in this follow-up study and provision of informed consent. Exclusion Criteria: 1. Participants who have moved away from their original community and have been living elsewhere for more than two years. 2. Participants whose contact information has changed or become invalid, resulting in loss of contact (those who remain uncontactable after three attempts to reach out).

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Number of Participants Who developed cardiovascular diseases.Through study completion, an average of 10 year

The diagnosis of cardiovascular diseases should be made according to the outcomes of carotid ultrasound and cardiac biomarkers.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Shanghai Changzheng Hospital🇨🇳 Shanghai, Shanghai Municipality, China

Open map

Tuo Li, MDContact

Email · Call +86-139198507887

Xin-yi Cai, MD.Contact

Email · Call +86-18396514027